Literature DB >> 15307107

Double minute chromosomes in monoblastic (M5) and myeloblastic (M2) acute myeloid leukemia: two case reports and a review of literature.

Leno Thomas1, Judith Stamberg, Ivana Gojo, Yi Ning, Aaron P Rapoport.   

Abstract

Double minutes (dmin) are small, paired chromatin bodies that lack a centromere and represent a form of extrachromosomal gene amplification. Although they have been found in a variety of solid tumors, their presence in hematological malignancies, especially acute myeloid leukemia (AML), is rare. In addition, the presence of dmin may be a mechanism for upregulated oncogene expression and is generally associated with a poor prognosis. We describe two patients who had dmin at initial presentation of AML, including the first case of M5a with C-MYC amplification on dmin, and another case with C-MYC amplification as the only cytogenetic finding. We review here a total of 33 cases with dmin in AML. C-MYC was amplified by the dmin in 25 cases, while other putative oncogenes were amplified in the other 8. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15307107     DOI: 10.1002/ajh.20151

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  15 in total

1.  A mechanism of palindromic gene amplification in Saccharomyces cerevisiae.

Authors:  Alison J Rattray; Brenda K Shafer; Beena Neelam; Jeffrey N Strathern
Journal:  Genes Dev       Date:  2005-06-01       Impact factor: 11.361

Review 2.  Double minutes, cytogenetic equivalents of gene amplification, in human neoplasia - a review.

Authors:  Erich Gebhart
Journal:  Clin Transl Oncol       Date:  2005-12       Impact factor: 3.405

3.  A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival.

Authors:  Siyuan Zheng; Jun Fu; Rahulsimham Vegesna; Yong Mao; Lindsey E Heathcock; Wandaliz Torres-Garcia; Ravesanker Ezhilarasan; Shuzhen Wang; Aaron McKenna; Lynda Chin; Cameron W Brennan; W K Alfred Yung; John N Weinstein; Kenneth D Aldape; Erik P Sulman; Ken Chen; Dimpy Koul; Roel G W Verhaak
Journal:  Genes Dev       Date:  2013-06-24       Impact factor: 11.361

4.  Myc roles in hematopoiesis and leukemia.

Authors:  M Dolores Delgado; Javier León
Journal:  Genes Cancer       Date:  2010-06

Review 5.  MYC oncogene in myeloid neoplasias.

Authors:  M Dolores Delgado; Marta Albajar; M Teresa Gomez-Casares; Ana Batlle; Javier León
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

6.  Small Circular DNAs in Human Pathology.

Authors:  Stephany Carolina Barreto; Madhuri Uppalapati; Amitabha Ray
Journal:  Malays J Med Sci       Date:  2014-05

7.  Diverse mechanisms of somatic structural variations in human cancer genomes.

Authors:  Lixing Yang; Lovelace J Luquette; Nils Gehlenborg; Ruibin Xi; Psalm S Haseley; Chih-Heng Hsieh; Chengsheng Zhang; Xiaojia Ren; Alexei Protopopov; Lynda Chin; Raju Kucherlapati; Charles Lee; Peter J Park
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582

8.  Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

Authors:  Sherif S Farag; Kellie J Archer; Krzysztof Mrózek; Amy S Ruppert; Andrew J Carroll; James W Vardiman; Mark J Pettenati; Maria R Baer; Mazin B Qumsiyeh; Prasad R Koduru; Yi Ning; Robert J Mayer; Richard M Stone; Richard A Larson; Clara D Bloomfield
Journal:  Blood       Date:  2006-03-07       Impact factor: 22.113

9.  FLT3 Amplification as Double Minute Chromosomes in a Patient with Chronic Myelomonocytic Leukemia.

Authors:  Heyang Zhang; Xiaoxue Wang; Shibo Li; Xianfu Wang; Xianglan Lu; Ming Li; Hua Wang; Ying Liu; Hui Pang; Lijun Zhang
Journal:  Dis Markers       Date:  2021-06-05       Impact factor: 3.434

10.  Identification of homogeneously staining regions in leukemia patients.

Authors:  Mohammad Heydarian Moghadam; Abolfazl Movafagh; Mirdavood Omrani; Kiandokht Ghanati; Mehrdad Hashemi; Farhikhteh Poursafavi; Hossein Darvish; Davood Zare Abdolahi; Milad Gholami; Mohammad Reza Heidari Rostamy; Shamsi Safari; Leyla Haghnejad; Reyhaneh Darehgazani; Niloofar Safavi Naeini; Mehdi Ghandehari Motlagh; Davar Amani
Journal:  J Res Med Sci       Date:  2013-04       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.